(Q38102671)

28 August 2017

Gene of the month: KRAS. (English)

1 reference

28 August 2017

Runjan Chetty

1

1 reference

PubMed ID

23626007

28 August 2017

Dhirendra Govender

series ordinal

2

1 reference

PubMed ID

23626007

28 August 2017

language of work or name

English

0 references

publication date

27 April 2013

1 reference

Journal of Clinical Pathology

28 August 2017

1 reference

28 August 2017

66

1 reference

28 August 2017

7

1 reference

28 August 2017

548-550

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

28 August 2017

1 reference

The importance of being K-Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

Guanine nucleotide exchange factors: activators of the Ras superfamily of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

Oncogenic Ras in tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

The activation of Akt/PKB signaling pathway and cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

Epidermal growth factor receptor mutations in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

KRAS mutations in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

Detection of high incidence of K-ras oncogenes during human colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201663

10.1136/JCLINPATH-2013-201663

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23626007